哈药股份
(600664)
| 流通市值：70.77亿 | | | 总市值：70.85亿 |
| 流通股本：25.19亿 | | | 总股本：25.21亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 15,456,578,104.4 | 11,493,851,773.09 | 7,703,387,875.14 | 3,931,549,972.98 |
| 营业收入 | 15,456,578,104.4 | 11,493,851,773.09 | 7,703,387,875.14 | 3,931,549,972.98 |
| 二、营业总成本 | 14,807,716,017.62 | 11,042,619,330.6 | 7,404,637,544.92 | 3,749,463,341.18 |
| 营业成本 | 11,404,770,476 | 8,588,124,892.61 | 5,793,745,399.27 | 2,946,131,823.93 |
| 税金及附加 | 118,187,139.07 | 84,963,094.24 | 55,640,782.69 | 27,670,067.14 |
| 销售费用 | 2,311,530,650.56 | 1,681,104,580.83 | 1,097,283,492.75 | 530,807,322.59 |
| 管理费用 | 839,497,248.57 | 604,338,948.36 | 399,376,715.31 | 203,460,628.32 |
| 研发费用 | 106,015,499.23 | 67,231,906.97 | 47,064,140.07 | 33,061,277.2 |
| 财务费用 | 27,715,004.19 | 16,855,907.59 | 11,527,014.83 | 8,332,222 |
| 其中:利息费用 | 56,468,349.57 | 42,251,465.02 | 28,287,333.86 | 15,794,531.87 |
| 其中:利息收入 | 47,096,752.5 | -34,837,345.27 | -23,128,558 | -11,289,382.54 |
| 加:投资收益 | 4,483,228.47 | 5,613,488.69 | - | - |
| 资产处置收益 | 1,333,760.51 | 1,532,380.04 | 1,511,780.08 | 98,960.09 |
| 资产减值损失(新) | -45,066,567.23 | -12,847,692.44 | -13,667,807.16 | -490,156.9 |
| 信用减值损失(新) | -33,657,291.52 | -18,460,080.29 | -13,074,683.86 | -7,582,318.75 |
| 其他收益 | 83,674,232.8 | 52,929,859.34 | 35,086,901.18 | 14,802,992.46 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 659,629,449.81 | 480,000,397.83 | 308,606,520.46 | 188,916,108.7 |
| 加:营业外收入 | 2,426,643.39 | 1,763,884.11 | 1,557,573.92 | 552,260.06 |
| 减:营业外支出 | 11,516,270.05 | 4,493,365.32 | 3,959,686.89 | 1,899,821.1 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 650,539,823.15 | 477,270,916.62 | 306,204,407.49 | 187,568,547.66 |
| 减:所得税费用 | 176,321,650.26 | 129,114,480 | 84,856,271.06 | 47,580,972.7 |
| 六、净利润 | 474,218,172.89 | 348,156,436.62 | 221,348,136.43 | 139,987,574.96 |
| 持续经营净利润 | 474,218,172.89 | 348,156,436.62 | 221,348,136.43 | 139,987,574.96 |
| 归属于母公司股东的净利润 | 395,263,436.89 | 290,501,340.84 | 182,712,480.59 | 122,293,236.02 |
| 少数股东损益 | 78,954,736 | 57,655,095.78 | 38,635,655.84 | 17,694,338.94 |
| (一)基本每股收益 | 0.16 | 0.12 | 0.07 | 0.05 |
| (二)稀释每股收益 | 0.16 | 0.12 | 0.07 | 0.05 |
| 八、其他综合收益 | 31,430.14 | -1,191,473.4 | -1,288,620.96 | 1,159,895.66 |
| 归属于母公司股东的其他综合收益 | 31,430.14 | -1,191,473.4 | -1,288,620.96 | 1,159,895.66 |
| 九、综合收益总额 | 474,249,603.03 | 346,964,963.22 | 220,059,515.47 | 141,147,470.62 |
| 归属于母公司股东的综合收益总额 | 395,294,867.03 | 289,309,867.44 | 181,423,859.63 | 123,453,131.68 |
| 归属于少数股东的综合收益总额 | 78,954,736 | 57,655,095.78 | 38,635,655.84 | 17,694,338.94 |
| 公告日期 | 2024-04-11 | 2023-10-27 | 2023-08-25 | 2023-04-28 |
| 审计意见(境内) | 标准无保留意见 | | | |